Primary Record
brimonidine
- In stock
- 2,367 g
- Purity
- 99.8 %
- CAS
- 59803-98-4
Compound Identifiers & Properties
- CAS
- 59803-98-4
- PubChem CID
- 2435
- SMILES
- C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
- Canonical SMILES
- Brc1c(NC2=NCCN2)ccc2nccnc12
Names & Synonyms
- brimonidine
- Bromoxidine
- 59803-98-4
- mirvaso
- Alphagan
- brimonidina
- brimonidinum
- Alphagan P
- UK 14,304
- Brimodine
- Lumify
- [3H]brimonidine
- BRIMONIDINE TARTRATE
- E6GNX3HHTE
- Brimonidine (INN)
- Brimonidine (tartrate)
- Brimonidine [INN:BAN]
- 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
- UNII-E6GNX3HHTE
- C11H10BrN5
- Brimonidine D-tartrate
- Brimonidine (Standard)
- Tocris-0425
- CHEMBL844
- Opera_ID_612
- RefChem:58237
- Lopac-U-104
- BRIMONIDINE [MI]
- UK-14304
- 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline
- BRIMONIDINE [INN]
- MLS000069370
- 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine
- DTXSID3045221
- MFCD00153878
- D03ACG
- D0AE3X
- D0GD9D
- brimonidine (UK14304)
- BRIMONIDINE [VANDF]
- AC1L1DO5
- AC1Q24IC
- AC1Q26LW
- cid_2435
- CHEBI:3175
- AGN-190342 FREE BASE
- Lopac0_001216
- SCHEMBL24670
- BRIMONIDINE [WHO-DD]
- DTXCID1025221
- GTPL520
- MLS001076349
- AGN 190342
- ARONIS24406
- BIDD:GT0649
- NSC-318825
- SCHEMBL275296
- UK-1430418 FREE BASE
- 5-bromo-6-(imidazolin-2-ylamino)quinoxaline
- GTPL5386
- orb1306736
- orb3025839
- SCHEMBL29374525
- UK 14304
- BDBM34572
- CTK5B0525
- HY-B0659R
- [3H]brimonidine (UK14304)
- BRN 0751629
- C11-H10-Br-N5
- CID2435
- D11AX21
- S01EA05
- XYLJNLCSTIOKRM-UHFFFAOYSA-N
- HMS3259P09
- HMS3263D14
- HMS3266O03
- HMS3411K05
- HMS3675K05
- HMS3887K07
- HMS5086B09
- SMR000058355
- AGN-190342
- 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-
- AMY22318
- BCP12632
- EX-A5415
- HY-B0659
- KS-00000F2V
- KS-000048KL
- MSK10706
- Tox21_110299
- Tox21_501216
- AC-162
- ANW-59812
- AR-1G7332
- EBC-06648
- NCGC00016069-09
- NSC318825
- PDSP1_000640
- PDSP2_000635
- s9508
- SBB080815
- ZINC21303210
- [3H]-UK14304
- AKOS005267239
- Brimonidine;AGN190342;UK14304
- LK 14304-18
- Tox21_110299_1
- AN-6804
- CCG-205290
- CS-2892
- DB00484
- FB19008
- GS-3236
- LP01216
- NC00638
- NSC 318825
- SDCCGSBI-0051183.P002
- TRA0032007
- UK 14304;AGN190342
- UK14304
- MRF-0000657
- NCGC00016069-01
- NCGC00016069-02
- NCGC00016069-03
- NCGC00016069-04
- NCGC00016069-05
- NCGC00016069-06
- NCGC00016069-07
- NCGC00016069-08
- NCGC00016069-10
- NCGC00016069-11
- NCGC00016069-12
- NCGC00016069-13
- NCGC00016069-24
- NCGC00023468-02
- NCGC00023468-04
- NCGC00023468-05
- NCGC00023468-06
- NCGC00023468-07
- NCGC00261901-01
- AJ-78420
- AK-35795
- BC215787
- CJ-16916
- CPD000058355
- J23.694B
- SAM002548958
- SY053060
- UK 14308
- UK-11957
- UK14,304
- Brimonidine 100 microg/mL in Acetonitrile
- Brimonidine (bioerodible, extended release)
- CAS-59803-98-4
- LS-142950
- ST2406733
- TC-148557
- UK-14,308
- 2436B
- B4132
- EU-0101216
- FT-0650586
- NS00006954
- U-104
- UK 14304 (tartrate);AGN190342 (tartrate)
- 5-Bromo-N-(2-imidazolin-2-yl)-6-quinoxalinamine
- EN300-50880
- UK 14304-18
- UK-14304-18
- 5-bromo-6-(imidazolidinylideneamino)quinoxaline
- 5-bromo-6-[2-imidazolin-2-ylamino]quinoxaline
- C07886
- C75796
- D07540
- UK 14,304-18
- UK-14,304-18
- 5-bromo-6-(2-imidazolidinylidenamino)quinoxaline
- 5-bromo-6-(2-imidazolin-2-ylamino) quinoxaline
- 5-Bromo-6-(2-imidazolin-2-ylamino)-quinoxaline
- 6-Quinoxalinamine,5-dihydro-1H-imidazol-2-yl)-
- (5-bromoquinoxalin-6-yl)-2-imidazolin-2-ylamine
- 2-[(5-Bromoquinoxalin-6-yl)amino]-2-imidazoline
- 5-Bromo-6-[(2-imidazolin-2-yl)amino]quinoxaline
- 803B984
- A832477
- A938411
- L000615
- Q577377
- SR-01000000023
- 5-Bromo-N-(4,5-dihydro-2-imidazolyl)quinoxalin-6-amine
- SR-01000000023-2
- SR-01000000023-4
- 5-brom-n-(4,5-dihydro-1h-imidazol-2-yl)chinoxalin-6-amin
- 5-bromo-N-(imidazolidin-2-ylidene)quinoxalin-6-amine
- BRD-K68264559-001-10-0
- BRD-K68264559-001-13-4
- BRD-K68264559-045-02-4
- BRD-K68264559-045-03-2
- BRD-K68264559-045-04-0
- 70359-46-5
- Z608061562
- 2-[(5-Bromoquinoxalin-6-yl)amino]-4,5-dihydro-1H-imidazole
- 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalineamine
- 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxaline-6-amine
- 6-Quinoxalinamine,5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-
- Brimonidine base/5-Bromo-6-(imidazolin-2-ylamino)quinoxaline
- (5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine
- 5-bromanyl-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
- 5-Bromo-N-[(4,5-dihydro-1H-imidazol)-2-yl]quinoxaline-6-amine
- 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- (9CI)
- 59308-98-4
- 7268-58-8
- 79570-19-7
- Bromoxidine;AGN190342;AGN 190342;AGN-190342;UK14304;UK 14304;UK-14304;UK 14,304